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Abstract
Background: The risk of acquiring tuberculosis by People living with HIV (PLHIV) could significantly be reduced
through provision of isoniazid preventive therapy (IPT). In Ethiopia, it is neither practiced well nor researched in
depth. Our objective was to assess IPT provision and awareness among PLHIV in Addis Ababa City Administration.
Methods: Between February 2008 and May 2008, a cross sectional facility-based survey was conducted by exit
interview of 406 PLHIV from six health facilities. The findings were analyzed and described in this report.
Results: The proportion of PLHIV ever had been provided with IPT were 74 of 231 TB free PLHIV (32.0%) and the
proportion of having information about IPT among study participants was 29.8%. Females were about two times
more informed about the provision of IPT in their health facilities than males [AOR (95%CI): 2.18 (1.31-3.61)].
Conclusions: We conclude that the practice of provision of IPT for PLHIV is high, but there is room for
improvement. Provision of INH for TB free PLHIV has to be strengthened with better diagnostic facilities to certainly
rule out active TB cases.
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Background
The spread of the HIV epidemic throughout sub-Saharan
Africa has been accompanied by up to a fourfold increase
in the number of TB cases registered by national TB pro-
grams [1]. Several researchers have reported the benefit of
IPT for PLHIV in reducing the incidence of tuberculosis
including in resource poor countries where TB infection
rates are very high [2-7]. Interventions for preventing and
treating TB include: IPT intensified case finding for active
TB and TB infection control [8]. The World Health Orga-
nization recommends IPT for all PLHIV in countries with
a prevalence of latent TB infection > 30%, and for all
PLHIV with documented latent TB infection or exposure
to an infectious TB case. In the same policy report it is
indicated that the combined use of IPT and antiretroviral
therapy among PLHIV significantly reduces new infections
[8]. Most IPT studies focused on issues related to adher-
ence by PLHIV [9,10].
Information about the status of IPT provision and
awareness of PLHIV regarding IPT in Ethiopia is lim-
ited. This is due to the absence of well standardized
information flow at all levels and scarcity of research
based evidences.
Therefore, this paper attempted to present the status




This is facility-based cross sectional descriptive study
which was conducted at one referral hospital and five
health centers in Addis Ababa, Ethiopia.
Setting
The study setting include Zewditu Memorial hospital
which is one of the HIV therapy and care hospital and five
health centers namely: Bole, T/Haymanot, Gulele, Kazan-
chis and Woreda 23 health centers to assess the status of
IPT provision and awareness among PLHIV attending
HIV chronic care clinics. Fifty eight percent of all health
facilities in the city provide TB/HIV collaborative services.
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Participants
The study participants include people living with HIV
and chronic follow up in the health facilities.
Sampling method
Using a single population proportion formula with
assumption of 50% prevalence of IPT practice in the
country, 5% margin of error and adding a 5% allowance
for interruption of participation, a sample of 403 study
participants was calculated. Randomly selected PLHIV
attending HIV chronic care clinics at the selected health
facilities in their follow-up care were interviewed at exit.
To allocate the number of PLHIV required to interview
at each facility, sampling with Proportional allocation to
their HIV patient load was applied.
Data collection
The data collection was conducted from February to May
2008. Three senior VCT counselors conducted the inter-
views and the principal investigator provided supportive
supervisions during data collection by checking complete-
ness and consistency of questionnaires. The interviewers
were recruited from health facilities other than the study
sites for minimizing interviewer bias. We used interviewer
administered questionnaire, which was adapted from
WHO guidelines prepared for monitoring and evaluation
of TB/HIV activities. As the questionnaire extracted from
WHO standard guideline which is the prime source for
national guideline for implementation of TB/HIV activities
in Ethiopia, its validity and reliability is acceptable.
Ethical clearance was obtained from Institutional Review
Board of Addis Ababa University and Addis Ababa City
Administration Health bureau. Permission was obtained
from authorities of the respective health facilities. The
interview was undertaken after ascertaining written con-
sents from study participants. The questionnaire did not
include any identifier of the interviewee.
Data analysis
SPSS version 11 was used for data entry and analysis. Data
was analyzed using frequency distribution and characteri-
zation of the study population and then logistic regression
was applied to identify factors associated with access to
IPT as a package of care.
Results
A total of 406 PLHIV, who were under HIV chronic care
follow-up in government health facilities in Addis Ababa
City Administration, participated in the study. Out of the
total respondents 252(62.1%) were females.
The mean age (± SD) of the study population was 36.27
(± 8.74) years. Three hundred and nine (76.1%) of the
participants were in the age group 25-44, 154 (37.9%)
were married and 128 (31.5%) were singles, 374 (92.1%)
were followers of Christian religion. Fifty two percent
had completed high school, 14.5% had at least a certifi-
cate after completing high school. The remaining 17.2%
and 16.5% accounted for primary completed and having
no formal education at the time of the study respectively.
One hundred twenty four (30.5%), ninety seven
(23.9%) and sixty eight (16.3%) were privately employed,
housewives and government employees by occupation
respectively; whereas 93 (22.9%) of study participants
were unemployed at the time of data collection.
Close to 85% of all study participants had become
more than six months since they know their positive
HIV status. Three hundred and thirty two (81.8%) of
these clients have already started ART in the health
facilities. Of those put under highly active antiretroviral
therapy (HAART), 188 (46.3%) were on ART for more
than one year.
Awareness about IPT
The proportion of PLHIV and without active TB who have
some information about IPT was 29.8% (Table 1).
Multiple logistic regression analysis with stepwise selec-
tion was used to examine potential effects of the socio-
demographic variables including age, sex, educational
level, marital status, occupation and other variables on
knowledge of access to IPT as a package of care for
PLHIV. Females (29.7%) were more likely to be informed
than males (18.8%) in pertaining to the provision of IPT in
their health facilities for those PLHIV having no active TB
[AOR (95%CI): 2.18 (1.31-3.61)].
In addition, those who completed secondary (27.6%)
and post secondary (30.5%) education were 2.5 and 3.5
times more likely than those non formally educated
(14.9%) to be informed on the availability of IPT [AOR
(95%CI): [2.55 (1.19-5.43), 3.47 (1.37-8.78)] respectively.
Information about the availability of IPT as a package of
care among PLHIV in the different health facilities did not
reveal statistically significant difference (Table 2).
Provision of IPT
The proportion of PLHIV who had ever been provided
with IPT was 74 of 231 TB free PLHIV (32.0%). This fig-
ure varied with health facilities, for example, in Gulele
Health Center no one out of five interviewed PLHIV with-
out active TB had been provided with IPT, whereas; in
Kazanchis Health Center eight out of nine eligible PLHIV
have been provided with IPT (Figure 1).
Discussion
As the focus for TB control by most public health experts
and clinicians in high burden areas is to find active TB
cases for prompt care and therapy, the findings in this
study for provision of IPT for eligible TB free PLHIV was
32.0%, this means there were considerable missed
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Table 1 Disease specific characteristics of people living with HIV at HIV chronic care clinics of public facilities in Addis
Ababa City Administration, February, 2008.
Variable Number Percent






Knowledge about IPT service availability in health facilities
Yes available 104 25.6
Not available 169 41.6
I don’t know 133 32.8
If the response to knowledge to IPT is not available, the reasons mentioned were. (n = 169)
I don’t know 74 43.8
Care takers don’t order 92 54.4
Other reasons 3 1.8
Placement of the drug for IPT to be collected, (n = 74)
HIV clinic 64 86.5
TB clinic 1 1.4
Work place 9 12.2
Length of being diagnosed for HIV positive
Less than 6 months 60 14.8
6 months-one year 87 21.4
More than one year 259 63.8
Length of being on HAART
Less than 6 months 70 17.2
6 months- one year 74 18.2
More than one year 188 46.3
Not yet started 74 18.2
n = 406
Table 2 Association of selected variables with Awareness about access to IPT as a package of care among PLHIV,
Addis Ababa City Administration, February, 2008.
Variable Access to IPT as a Package of Care Crude Odds Ratio (95%CI) Adjusted Odds Ratio (95%CI)
Yes (104) No (302)
Sex
Male 29 125 1.00 1.00
Female 75 177 1.83(1.12, 2.97) 2.18(1.31, 3.61)
Educational Status
No formal education 10 57 1.00 1.00
Primary (1-6) 18 52 1.97(0.84, 4.66) 2.20(0.93, 5.25)
Secondary (7-12) 58 152 2.17(1.04, 4.54) 2.55(1.19, 5.43)
Post secondary (12+) 18 41 2.50(1.05, 5.98) 3.47(1.37, 8.78)
Time since diagnosed for HIV
Less than 6 months 10 50 1.00 1.00
6 months and above 111 235 2.36(1.16, 4.83) 2.26(1.06, 4.85)
Type of health facility
Hospital 74 206 1.00 1.00
Health center 4 20 0.53(0.53, 1.42) 0.98(0.58, 1.64)
n = 406
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opportunities. In addition, comparable proportion of
interviewed study subjects reported to know (~30%)
about the availability of IPT in the respective health facil-
ities. The low coverage of IPT was due to lack of consis-
tency among health care providers towards providing
IPT, shortage of Isoniazid and inequitable availability of
investigation setups (X-ray, Fine Needle Aspirations, etc.)
at the different health facilities to apparently rule out
active TB.
Study participants who completed secondary and post
secondary education were found to be better informed
about the availability of IPT more than those who were
not formally educated. These findings may suggest that
educated people are more concerned about their disease
patterns and seek additional information better than
those of less educated. This might be due to better
access to printed media than the less educated counter-
parts beyond other source of information. This finding
was also similar with findings in other countries (China,
Malawi and Zambia) [11].
In addition, length of being diagnosed for HIV positive
and being informed about IPT had a significant associa-
tion. Those who knew their HIV positive status for more
than six months were about two times more likely to be
informed about availability of IPT as a package of HIV
care than those who were less than six months. This
showed that as people stay longer learning about their
HIV status, they become more and more aware of their
health conditions and opportunistic infections.
In this study females were more informed about the
availability of IPT in their health facilities as a package of
HIV care for PLHIV than males. This is in contrary to
most findings; a study in rural Vietnamese showed males
were two times more informed than the females [12].
Our result was also in contrary to a previous finding
where higher proportion of males (87%) had some kind
of educational attainment than females (75%) indicating
better access to printed media in Addis Ababa [13].
However, it is very difficult to make a strong conclusion
as the study participants self-select health facilities or it
maybe due to men going to private facilities as they are
better off in economic status than women.
IPT is one of the key interventions recommended by
WHO in 1998 to reduce the burden of TB in PLHIV;
yet implementation of IPT had been very low in differ-
ent countries [14]. The proportion of PLHIV who were
free from TB but provided with IPT was only 32.0%.
This illustrated the missed opportunities in the preven-
tion of TB in high burden countries such as Ethiopia.
However, the proportion of PLHIV in Ethiopia receiving
IPT is considerably higher than in most other countries.
Globally, only 27,000 PLHIV without active TB were
started on IPT (0.1% of the 33 million people estimated
to be infected with HIV), almost all of whom were in
Botswana [15]. In another study in Italy, for example;
the number of people actually starting IPT was very
low. This was because of the small number who had a
positive TST, contraindications to isoniazid and refusal
of the eligible to the offered IPT [16].
Generally, provision of IPT among PLHIV in develop-
ing countries is linked to operational problems and
Ethiopia is not exceptional. There is no system of doing
the TST due to lack of national protocol for provision
of IPT for eligible PLHIV, lack of trained personnel who
do the TST, lack of supply of the test as well as pro-
blems related to administration of the TST and follow
up.
This study is limited to primary data sources and lacks
supportive evidence from secondary data on the TB/
HIV collaborative activities. Interviewer and/or observa-
tion bias might not be avoided as all the data collectors
were health professionals.
Conclusions
We conclude that the practice of provision of IPT for
PLHIV is high, but there is room for improvement.
Figure 1 Provision of IPT in relation to TB free people living with HIV across the health facilties, Addis Ababa City Administration,
February 2008. n = 231.
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Strengthening of the implementation of IPT among
PLHIV through capturing missed opportunities in all
health facilities is recommended.
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